Publisher Correction: Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS)
- 1 April 2019
- journal article
- correction
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 54 (12) , 2117-2119
Abstract
The original version of this article included some minor typesetting errors in Table 1–a corrected version of which is provided in this correction article and has been corrected in the original article–and one error in text, which has been corrected in the original article. Furthermore, the article was erroneously published with the copyright holders as ‘Springer Nature Limited’, however, since the article is Open Access, the copyright holders should in fact be ‘The Author(s)’. This has also been corrected in the original article.Keywords
This publication has 16 references indexed in Scilit:
- Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failureBlood, 2016
- Escalation to High-Dose Defibrotide in Patients with Hepatic Veno-Occlusive DiseaseTransplantation and Cellular Therapy, 2015
- Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomesBone Marrow Transplantation, 2015
- CP-129 Defibrotide for sinusoidal obstruction syndrome: a single centre experienceEuropean Journal of Hospital Pharmacy, 2014
- Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding TrialTransplantation and Cellular Therapy, 2010
- Treatment of Sinusoidal Obstruction Syndrome With Defibrotide: A Single-Center ExperienceTransplantation Proceedings, 2007
- Defibrotide for the treatment of hepatic veno‐occlusive disease in childrenPediatric Blood & Cancer, 2006
- Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early interventionBone Marrow Transplantation, 2003
- Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcomeBlood, 2002
- Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use studyBritish Journal of Haematology, 2000